Victrex (OTCMKTS:VTXPF) Lifted to Hold at Zacks Investment Research

Victrex (OTCMKTS:VTXPFGet Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, reports.

According to Zacks, “Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. “

Separately, UBS Group reduced their price objective on shares of Victrex from GBX 2,150 ($27.40) to GBX 1,750 ($22.30) in a research report on Friday, April 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,530.33.

Shares of VTXPF stock remained flat at $$23.07 during trading hours on Wednesday. 48 shares of the stock traded hands, compared to its average volume of 199. Victrex has a one year low of $22.00 and a one year high of $36.50. The company has a quick ratio of 2.99, a current ratio of 4.24 and a debt-to-equity ratio of 0.03. The company’s fifty day simple moving average is $24.69 and its 200 day simple moving average is $28.54.

About Victrex (Get Rating)

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities.

Recommended Stories

Get a free copy of the Zacks research report on Victrex (VTXPF)

For more information about research offerings from Zacks Investment Research, visit

Analyst Recommendations for Victrex (OTCMKTS:VTXPF)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with's FREE daily email newsletter.